The generic drugs distribution companies in Nan involve firms that specialize in the procurement, warehousing, and distribution of non-branded pharmaceuticals. These companies play a vital role in ensuring affordability and accessibility in healthcare by providing generic alternatives to brand-name drugs. With new regulations and continuous advancements in production techniques, these companies are optimizing their supply chains to reduce costs and expand their market reach. An interesting trend is the increasing collaboration between manufacturers and distributors to launch new generics faster, thereby meeting the urgent healthcare needs of various populations.

This list features 26 companies across the globe specializing in generic drug distribution. Operating from countries like Canada, Brazil, and India, these firms vary in size from 200 to over 17,000 employees. Established between 1935 and 2022, they offer a wide range of therapeutic products focused on affordability and quality, indicating a strong global presence in the industry beneath well-established brand names.

Continue reading to explore the top generic drugs distribution companies.

Top 26 Generic Drugs Distribution Companies

1. Apotex Inc.

• Website: apotex.com
• Ownership type: Private Equity
• Headquarters: Toronto, Ontario, Canada
• Employee distribution: Canada 68%, India 17%, Mexico 8%, Other 7%
• Latest funding: September 2022
• Founded year: 1974
• Headcount: 10001+
• LinkedIn: apotex-inc-

Apotex Inc. is a Canadian-based pharmaceutical company founded in 1974, specializing in the production and distribution of generic medications. With a workforce exceeding 10,000 employees, the company operates on a global scale, offering over 300 products across more than 115 countries. Apotex serves healthcare providers, pharmacies, and patients, focusing on delivering affordable alternatives to brand-name drugs for various health conditions. The company emphasizes quality and accessibility, ensuring that its products meet rigorous standards. Apotex is also involved in research and development, continuously working to expand its product offerings and improve healthcare solutions. Their commitment to corporate responsibility is evident in their initiatives aimed at environmental sustainability and community support.

2. Ems

• Website: ems.com.br
• Ownership type: Private
• Headquarters: Hortolândia, Sao Paulo, Brazil
• Employee distribution: Brazil 99%, Other 1%
• Latest funding: Other (Debt), $91.1M, August 2024
• Founded year: 1964
• Headcount: 1001-5000
• LinkedIn: ems

Ems, founded in 1964 and based in Hortolândia, São Paulo, Brazil, is a private pharmaceutical manufacturer that specializes in generic medications. With a workforce of over 12,000 employees, the company has carved out a significant position in the Brazilian pharmaceutical industry, particularly in the sales and distribution of generic drugs. Ems is committed to providing affordable medication options to healthcare providers and consumers alike. The company has been recognized for its contributions to the industry, including accolades for its quality and innovation. Recently, Ems secured funding amounting to approximately 91 million USD, which underscores its active role in the market and its potential for growth. Ems continues to focus on enhancing access to essential medications, making it a relevant entity in the generic drugs distribution sector.

3. Intas Pharmaceuticals

• Website: intaspharma.com
• Ownership type: Private Equity
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 99%, Other 1%
• Latest funding: October 2022
• Founded year: 2000
• Headcount: 10001+
• LinkedIn: intas-biopharmaceuticals

Intas Pharmaceuticals Limited, founded in 2000 and based in Ahmedabad, Gujarat, India, is a private equity-owned pharmaceutical company that focuses on the development, manufacturing, and marketing of generic therapeutic drugs. With a workforce exceeding 17,000 employees, Intas has established a significant global footprint, serving healthcare professionals and organizations in more than 85 countries. The company is dedicated to addressing unmet medical needs through innovative products and a strong commitment to quality. Intas has a comprehensive product portfolio that includes a wide range of formulations, from tablets to injectables and biosimilars. Their R&D efforts are robust, with a significant portion of their turnover reinvested into research and development, showcasing their commitment to advancing healthcare solutions. Intas operates under the Accord Healthcare brand in various international markets, further solidifying its presence in the global pharmaceutical landscape.

4. Alvogen

• Website: alvogen.com
• Ownership type: Corporate
• Headquarters: Montville, New Jersey, United States (USA)
• Latest funding: Other (Debt), $669.0M, March 2025
• Founded year: 2009
• Headcount: 1001-5000
• LinkedIn: alvogen

Alvogen is a pharmaceutical company based in Montville, New Jersey, founded in 2009. The company specializes in the development, manufacturing, and marketing of generic medications, injectables, and over-the-counter products. Alvogen serves healthcare providers, pharmacies, and patients, with a mission to enhance access to high-quality medicines at affordable prices. The company operates a significant manufacturing facility in Norwich, New York, which has a long-standing regulatory track record. Alvogen's product offerings include a wide range of formulations, such as solid oral doses, injectables, and transdermal patches, with a focus on complex and difficult-to-make pharmaceuticals. With over 50 products currently on the market and a strong pipeline fueled by extensive R&D capabilities, Alvogen is committed to quality and innovation in the pharmaceutical industry. The company has also secured substantial funding, with a recent amount of $669 million, indicating its potential for growth and expansion in the competitive landscape of generic drugs.

5. Generis Farmacêutica

• Website: generis.pt
• Ownership type: Corporate
• Headquarters: Amadora, Lisbon, Portugal
• Employee distribution: Portugal 99%
• Latest funding: $142.9M, January 2017
• Founded year: 2006
• Headcount: 201-500
• LinkedIn: generis-farmaceutica-sa

Generis Farmacêutica, based in Amadora, Lisbon, Portugal, is a pharmaceutical company that specializes in the production and distribution of generic medications. Established in 2006, the company has grown to employ around 396 individuals, primarily serving the Portuguese market. Generis is dedicated to ensuring access to affordable healthcare solutions, focusing on quality in its manufacturing processes. The company operates a modern facility capable of producing up to 30 million packages annually, which supports its extensive portfolio of generic drugs. Generis is a key partner for hospitals in Portugal, providing a wide range of medications that contribute to the healthcare system. Additionally, the company is involved in export activities, distributing its products globally, which enhances its relevance in the pharmaceutical industry.

6. Orifarm

• Website: orifarm.com
• Ownership type: Family Owned
• Headquarters: Odense, Denmark
• Employee distribution: Denmark 69%, Poland 11%, Germany 5%, Other 14%
• Founded year: 1994
• Headcount: 1001-5000
• LinkedIn: orifarm

Orifarm, based in Odense, Denmark, is a family-owned pharmaceutical company founded in 1994. The company specializes in the distribution of generic and parallel imported pharmaceuticals, ensuring that pharmacies and healthcare providers have reliable access to medications. With a workforce of over 1,200 employees, Orifarm operates across various European countries and the United States, highlighting its significant presence in the pharmaceutical market. The company adheres to strict quality and safety standards, comparable to those of original manufacturers, and is approved for parallel importation by local authorities. Orifarm's commitment to quality is reflected in its comprehensive quality control processes, which include regular audits and compliance with Good Distribution Practice (GDP) guidelines. Their focus on generics not only provides cost-effective options for consumers but also contributes to the overall efficiency of the healthcare system.

7. Opsonin Pharma Ltd

• Website: opsonin-pharma.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 99%
• Founded year: 1956
• Headcount: 5001-10000
• LinkedIn: opsonin-pharma

Opsonin Pharma Ltd, based in Dhaka, Bangladesh, is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic medicines for human use. Founded in 1956, Opsonin has grown to manufacture over 350 brands, offering more than 800 SKUs of pharmaceutical products. The company is dedicated to improving healthcare quality both locally and internationally, ensuring access to affordable medications for healthcare providers and consumers alike. Opsonin's product range includes various therapeutic classes, such as antibiotics, antiulcerants, and cardiovascular medicines. The company has also ventured into agrovet products and consumer health items. With a strong focus on quality, Opsonin adheres to stringent international regulatory standards, including those set by the US-FDA and EU. Their commitment to innovation is evident in their advanced manufacturing facilities, which are designed to meet global compliance requirements. Opsonin has established a significant export network, reaching markets in Asia, Africa, and the Middle East, thereby enhancing its global footprint in the pharmaceutical industry.

8. ratiopharm

• Website: ratiopharm.de
• Ownership type: Corporate
• Headquarters: Ulm, Baden-Württemberg, Germany
• Employee distribution: Germany 58%, Austria 22%, Spain 13%, Other 6%
• Latest funding: $4.0B, March 2010
• Founded year: 1973
• Headcount: 1001-5000
• LinkedIn: ratiopharm

ratiopharm GmbH, based in Ulm, Baden-Württemberg, Germany, is a pharmaceutical company that has been operational since 1973. The company specializes in the production and distribution of generic and over-the-counter medications, catering to pharmacies and consumers alike. With a workforce of approximately 581 employees, ratiopharm is committed to providing affordable health solutions across a wide array of products. Their offerings include both prescription and non-prescription medications, with a notable focus on generics. The company serves a significant market in Germany, Austria, Spain, and Portugal, ensuring that essential medications are accessible to a broad audience. As part of the Teva Group, ratiopharm benefits from advanced research and technology, which supports their mission to deliver quality products at fair prices. Their commitment to sustainability and social responsibility further underscores their role in the pharmaceutical industry.

9. Medochemie Ltd

• Website: medochemie.com
• Ownership type: Private
• Headquarters: Limassol, Limassol, Cyprus
• Employee distribution: Cyprus 46%, Greece 13%, Romania 6%, Other 35%
• Founded year: 1976
• Headcount: 1001-5000
• LinkedIn: medochemie-ltd

Medochemie Ltd, based in Limassol, Cyprus, is a pharmaceutical company that specializes in the development, manufacturing, and distribution of both branded generic and patented medications. Established in 1976, the company has grown to operate in 122 countries, serving healthcare providers and organizations worldwide. Medochemie boasts 15 manufacturing facilities, including nine in Cyprus, one in the Netherlands, and five in Vietnam, which are equipped to produce a wide range of pharmaceutical products. The company holds over 5,145 marketing authorizations for approximately 630 different products across more than ten therapeutic categories. Medochemie is committed to quality, adhering to stringent Good Manufacturing Practices (cGMP) and European guidelines. With a workforce of around 2,000 employees, the company is focused on delivering reliable and affordable drug treatments globally, while also engaging in contract manufacturing and licensing partnerships.

10. Joswe Medical

• Website: joswe.com
• Ownership type: Private
• Headquarters: Amman, Amman Governorate, Jordan
• Employee distribution: Jordan 76%, Iraq 10%, Saudi Arabia 8%, Other 6%
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: joswe-medical

Joswe Medical, founded in 1996, is a private pharmaceutical manufacturer located in Amman, Jordan. The company is dedicated to developing and producing high-quality branded first generic medicines. With a workforce of approximately 439 employees, Joswe Medical has made significant strides in the pharmaceutical sector, particularly within the MENA region. Their product offerings span over 14 therapeutic categories, including CNS, cardiovascular, and anti-infective medications. Joswe Medical is recognized as the first company in Jordan to manufacture quality branded first generic CNS medicines. The company is committed to increasing the availability and affordability of critical medications, ensuring that healthcare providers, pharmacies, and patients have access to essential treatments. Joswe Medical adheres to strict quality and compliance standards, aligning with various regulatory authorities, which underscores their commitment to safety and efficacy in their products.

11. Globalpharma LLC

• Website: globalpharma.ae
• Ownership type: Corporate
• Headquarters: Dubai, Dubai, United Arab Emirates (UAE)
• Employee distribution: United Arab Emirates 78%, Saudi Arabia 17%, Other 4%
• Latest funding: $30.0M, September 2021
• Founded year: 1998
• Headcount: 201-500
• LinkedIn: global-pharma-llc

Globalpharma LLC, founded in 1998 and based in Dubai, is a pharmaceutical manufacturer that specializes in the production and distribution of generic medicines. The company operates two manufacturing plants that adhere to current Good Manufacturing Practice (cGMP) standards, ensuring high-quality production. Globalpharma's product portfolio includes a wide array of medications, such as anti-infectives, NSAIDs, vitamins, and herbal medicines, catering to various health conditions. They have established a strong market presence in the GCC and select African markets, launching new products to meet the evolving needs of patients. The company is a wholly owned subsidiary of Dubai Investments PJSC and has received funding of $30 million as of September 2021, which supports its growth and expansion initiatives. Globalpharma is dedicated to collaborating with healthcare professionals to enhance patient care and promote medical education in the region.

12. Ultra Laboratorios

• Website: ultralaboratorios.com.mx
• Ownership type: Private
• Headquarters: Guadalajara, Jalisco, Mexico
• Employee distribution: Mexico 100%
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: ultra-laboratorios-s-a--de-c-v-

Ultra Laboratorios S.A. de C.V. is a Mexican pharmaceutical manufacturer founded in 2001, located in Guadalajara, Jalisco. The company specializes in the development, manufacturing, and distribution of generic medicines, serving healthcare professionals, pharmacies, and consumers. Ultra Laboratorios is recognized for its commitment to high-quality, safe, and effective pharmaceutical products across various therapeutic classes, including antibiotics, antivirals, antifungals, and more. With a robust research and development department, the company focuses on innovation and continuous improvement in its processes. Ultra Laboratorios operates a state-of-the-art production facility designed with advanced technology, allowing them to produce millions of oral solid medications annually. Their mission emphasizes improving health and well-being by providing accessible medicines. The company has established a strong presence throughout Mexico, ensuring that their products meet the needs of healthcare providers and patients alike.

13. Zydus Pharmaceuticals (USA) Inc.

• Website: zydususa.com
• Ownership type: Private
• Headquarters: Pennington, New Jersey, United States (USA)
• Employee distribution: United States (USA) 56%, India 40%, Other 4%
• Founded year: 2005
• Headcount: 51-200
• LinkedIn: zydus-pharmaceuticals-usa-inc-

Zydus Pharmaceuticals (USA) Inc., based in Pennington, New Jersey, is a pharmaceutical company that focuses on the manufacturing and distribution of generic and branded medications. Founded in 2005, Zydus has grown to offer over 500 stock-keeping units (SKUs) in the U.S. market, with a strong emphasis on FDA-approved products aimed at enhancing patient health. The company is part of Zydus Lifesciences, a global healthcare provider with a significant footprint in over 50 countries. Zydus Pharmaceuticals is recognized for its commitment to quality and affordability, serving healthcare providers and patients who depend on their medications. The company has filed over 129 drug master files and has received final USFDA approval on 287 Abbreviated New Drug Applications (ANDAs), with many more in development. Their facilities are equipped to produce a wide range of dosage forms, including tablets, capsules, and injectables, ensuring they meet the needs of the market effectively.

14. Synthon

• Website: synthon.com
• Ownership type: Private Equity
• Headquarters: Nijmegen, Gelderland, Netherlands
• Employee distribution: Spain 38%, Netherlands 23%, Chile 15%, Other 25%
• Latest funding: December 2024
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn: synthon

Synthon, founded in 1991 and based in Nijmegen, Netherlands, is a pharmaceutical company that specializes in the development, manufacturing, and commercialization of complex generic medicines. With a workforce of approximately 1,320 employees, Synthon has established a significant presence in the global pharmaceutical market. The company operates a vertically integrated manufacturing network, ensuring high-quality production and reliable supply of active pharmaceutical ingredients (APIs) and finished products. Synthon's portfolio includes a wide range of generic medications across multiple therapeutic areas, including oncology, central nervous system disorders, and cardiovascular health. Their commitment to innovation is evident in their investment in research and development, which aims to create safe and effective medicines that are accessible to patients worldwide. Synthon also emphasizes partnerships with healthcare providers and pharmaceutical companies to enhance the distribution and commercialization of their products, further solidifying their role in the generic drugs sector.

15. betapharm Arzneimittel GmbH

• Website: betapharm.de
• Ownership type: Corporate
• Headquarters: Augsburg, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: $577.4M, March 2006
• Founded year: 1993
• Headcount: 10001+
• LinkedIn: betapharm-arzneimittel-gmbh

betapharm Arzneimittel GmbH, founded in 1993 and based in Augsburg, Bavaria, Germany, specializes in the production and distribution of generic medications. The company serves pharmacies and healthcare professionals, emphasizing the importance of affordable and high-quality pharmaceutical products. As part of the international Dr. Reddy’s Laboratories group since 2006, betapharm has strengthened its position in the market. They offer a wide range of products, covering over 150 active ingredients in more than 900 forms, addressing various medical needs, including cardiovascular, neurological, and pain management. Their commitment to improving patient care is evident in their initiatives to provide accessible medication options and patient information resources. With a workforce of around 150 employees, betapharm is dedicated to enhancing healthcare delivery in Germany.

16. Bluefish Pharmaceuticals

• Website: bluefishpharma.com
• Ownership type: Private
• Headquarters: Stockholm, Stockholm, Sweden
• Employee distribution: India 66%, Sweden 17%, Iraq 6%, Other 11%
• Founded year: 2005
• Headcount: 51-200
• LinkedIn: bluefish-pharmaceuticals-group

Bluefish Pharmaceuticals, founded in 2005 and based in Stockholm, Sweden, is a private pharmaceutical company dedicated to providing affordable generic medications. With a workforce of around 141 employees, the company operates across 13 European countries, delivering high-quality healthcare solutions to pharmacies, wholesalers, and healthcare providers. Bluefish focuses on developing generic versions of established medications, ensuring that they meet rigorous safety and efficacy standards. Their product range spans various therapeutic areas, including CNS, cardiology, oncology, and pain management. The company emphasizes collaboration with development and manufacturing partners to maintain quality and optimize their supply chain. Bluefish's commitment to innovation and cost-effectiveness aims to enhance patient access to essential treatments, contributing to the sustainability of healthcare systems in Europe.

17. Rising Pharmaceuticals

• Website: risingpharma.com
• Ownership type: Corporate
• Headquarters: East Brunswick, New Jersey, United States (USA)
• Employee distribution: United States (USA) 53%, India 46%
• Latest funding: March 2019
• Founded year: 2019
• Headcount: 201-500
• LinkedIn: rising-pharmaceuticals-inc.

Rising Pharmaceuticals, established in 2019 and based in East Brunswick, New Jersey, is a pharmaceutical company that specializes in the manufacturing and distribution of prescription generics, over-the-counter solutions, and specialty products. With a workforce of approximately 307 employees, the company serves healthcare providers, pharmacies, and patients, emphasizing high-quality pharmaceutical solutions tailored to various health needs. Rising Pharmaceuticals operates with a strong commitment to quality assurance, ensuring that all products meet rigorous standards from research and development through to production and delivery. Their product offerings include a wide range of medications, and they are actively expanding their capabilities, particularly in sterile dosage forms and injectables. This growth reflects their ambition to enhance their presence in the pharmaceutical market and address the evolving needs of healthcare.

18. Calox International C.A.

• Website: calox.com
• Ownership type: Private
• Headquarters: Caracas, Capital, Venezuela
• Employee distribution: Venezuela 77%, Costa Rica 11%, Nicaragua 3%, Other 8%
• Founded year: 1935
• Headcount: 201-500
• LinkedIn: calox-international-c.a.

Calox International C.A. is a pharmaceutical company based in Caracas, Venezuela, with a history dating back to 1935. The company specializes in the manufacturing and marketing of quality medications, particularly focusing on generic drugs. They cater to a wide range of clients, including healthcare institutions, pharmacies, and hospitals, ensuring that essential pharmaceutical products are accessible to meet health needs. Calox has a significant presence in Central America, having expanded its operations to countries such as Costa Rica, Nicaragua, and Ecuador. The company is recognized as the first generic drug laboratory in Venezuela and holds a prominent position in the market, being the top distributor of generic medications in Costa Rica and the Dominican Republic. Their commitment to quality and customer satisfaction is evident in their extensive product portfolio, which includes a variety of therapeutic lines. Calox continues to pursue growth opportunities, aiming to expand its reach further into the Andean region.

19. Healthcare Pharmaceuticals Limited

• Website: hplbd.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 98%, Other 2%
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: healthcare-pharmaceuticals-ltd

Healthcare Pharmaceuticals Limited (HPL), founded in 1996 and based in Dhaka, Bangladesh, is a private pharmaceutical manufacturer that specializes in branded generic medicines. With a workforce of over 1,200 employees, HPL has established itself as a significant player in the pharmaceutical industry. The company produces a comprehensive range of products that span various therapeutic classes, including antibiotics, anti-diabetics, and oncology medications. HPL is committed to ensuring high-quality medications for effective patient treatment, which is evident in its robust quality management systems and adherence to international standards. The company also emphasizes research and development, focusing on innovative drug delivery systems and advanced formulations. HPL's distribution services are supported by its sister concern, Healthcare Distribution Company, which further strengthens its market presence. HPL's products are not only available in Bangladesh but are also marketed in several international markets, showcasing its ambition to expand its footprint in the global pharmaceutical landscape.

20. Pharma International Company

• Website: axantia.com
• Ownership type: Private
• Headquarters: Amman, Amman Governorate, Jordan
• Employee distribution: Jordan 57%, Iraq 15%, Saudi Arabia 9%, Other 20%
• Founded year: 1994
• Headcount: 501-1000
• LinkedIn: pharma-international

Pharma International Company (PIC), based in Amman, Jordan, is a pharmaceutical entity that has been active since its establishment in 1994. Officially commencing operations in 2001, PIC is dedicated to the manufacturing of branded generic medications. The company aims to enhance health outcomes and lower the cost of care for patients. With a product range that exceeds 200 items, PIC addresses various therapeutic areas, ensuring a broad reach across the Middle East and Africa. As part of Axantia, which acquired PIC in 2014, the company has access to enhanced resources and expertise, allowing it to expand its product offerings and market presence effectively. PIC's commitment to quality and patient well-being positions it as a significant player in the pharmaceutical industry.

21. Alter Pharma Group

• Website: alterpharmagroup.be
• Ownership type: Private Equity
• Headquarters: Anderlecht, Brussels, Belgium
• Latest funding: December 2017
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: alter-pharma

Alter Pharma Group, now rebranded as A.forall, is a pharmaceutical company based in Anderlecht, Brussels, Belgium. Founded in 2010, the company operates with a mission to make affordable medicines available to all. A.forall specializes in the development and distribution of generic pharmaceuticals, focusing on injectable generics and value-added products. They have successfully marketed over 30 molecules across Europe and the United States, addressing critical medication shortages and ensuring that patients receive uninterrupted treatment. The company has signed more than 250 distribution and licensing deals with prominent pharmaceutical firms, showcasing their active role in the market. A.forall also emphasizes sustainability and social responsibility, integrating these principles into their operations. With a workforce of around 77 employees, they maintain a presence in multiple countries, including offices in Ireland and the U.S.

22. Les Laboratoires FRATER-RAZES

• Website: frater-razes.com
• Ownership type: Private
• Headquarters: Algiers [El Djazaïr], Algiers, Algeria
• Employee distribution: Algeria 99%
• Founded year: 1992
• Headcount: 1001-5000
• LinkedIn: laboratoires-frater-razes

Les Laboratoires FRATER-RAZES, founded in 1992 by Dr. Abdelhamid Cherfaoui, is a prominent pharmaceutical company based in Algiers, Algeria. The company specializes in the production and distribution of a wide range of medications, including generic drugs and biosimilars. With a workforce of over 500 employees, they have developed a robust industrial complex equipped with advanced technologies that meet international standards. Their commitment to quality is evident through their adherence to Good Manufacturing Practices (GMP) and ISO 9001:2015 certification. FRATER-RAZES actively engages with healthcare professionals and institutions, providing training and support to enhance the understanding and visibility of their products. Their extensive portfolio includes various therapeutic areas, ensuring they meet the healthcare needs of the Algerian population.

23. Morningside Pharmaceuticals Ltd

• Website: morningsidepharm.com
• Ownership type: Private
• Headquarters: Loughborough, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Founded year: 1991
• Headcount: 51-200
• LinkedIn: morningside-pharmaceuticals-ltd

Morningside Pharmaceuticals Ltd, based in Loughborough, England, is a pharmaceutical manufacturer and wholesaler that specializes in the production and distribution of both generic and branded medicines. Established in 1991, the company has built a reputation for delivering high-quality healthcare products to various healthcare providers, including NHS Trusts and pharmacies. Morningside operates with a strong focus on ethical practices and customer care, ensuring that their products are not only effective but also accessible. With a robust supply chain, they guarantee timely delivery of their products, which include a wide range of generic medicines. The company has received numerous marketing authorizations in the UK and globally, covering key therapeutic areas. Morningside has also been recognized for its commitment to quality, holding several accreditations, including Good Manufacturing Practice (GMP) and ISO 9001:2015. Their recent acquisition by Aspire Pharma positions them for enhanced growth and a broader market presence, further solidifying their role in the pharmaceutical industry.

24. Pharma Dynamics (Pty) Ltd

• Website: pharmadynamics.co.za
• Ownership type: Corporate
• Headquarters: Cape Town, Western Cape, South Africa
• Employee distribution: South Africa 98%, Philippines 2%
• Latest funding: March 2015
• Founded year: 2001
• Headcount: 51-200
• LinkedIn: pharma-dynamics-pty-ltd

Pharma Dynamics (Pty) Ltd, founded in 2001 and based in Cape Town, South Africa, is a corporate entity specializing in the distribution of generic medications. The company has carved out a niche in cardiovascular health, boasting a portfolio of 25 market-leading brands. It has consistently ranked as the largest supplier of cardiovascular pharmaceuticals in South Africa, both in terms of value and volume. With a workforce of approximately 175 employees, Pharma Dynamics operates not only in South Africa but also has a presence in several neighboring countries, including Namibia, Botswana, Zambia, Zimbabwe, Mozambique, Angola, and Kenya. The company is a wholly owned subsidiary of Lupin Limited, a global pharmaceutical firm. Pharma Dynamics is dedicated to social responsibility, engaging in various community development programs aimed at education and youth empowerment, which reflects its commitment to improving healthcare access and outcomes in the region.

25. Solco Healthcare US LLC.

• Website: solcohealthcare.com
• Ownership type: Private
• Headquarters: United Kingdom (UK)
• Employee distribution: United States (USA) 72%, China 28%
• Founded year: 2009
• Headcount: 201-500
• LinkedIn: solco-healthcare-us-inc.

Solco Healthcare US LLC, established in 2009, is a private pharmaceutical company based in Somerset, New Jersey. The company focuses on the marketing and distribution of generic medications, providing a wide array of high-quality products to pharmacies and healthcare providers. Solco is dedicated to ensuring affordable access to essential medications, operating under rigorous quality standards. As a fully owned subsidiary of Prinston Pharmaceuticals Inc. and Zhejiang Huahai Pharmaceuticals, Solco benefits from the expertise of its parent companies in drug development and manufacturing. The company currently markets 45 products and has a robust pipeline with over 40 additional products awaiting FDA approval. Solco's production capabilities are significant, with the capacity to produce 20 billion tablets annually, underscoring its commitment to meeting market demands. Their recent FDA approvals for various medications highlight their active role in the pharmaceutical industry and their focus on innovation and quality.

26. Pharmascience

• Website: pharmascience.com
• Ownership type: Private
• Headquarters: Montreal, Quebec, Canada
• Employee distribution: Canada 93%, Other 7%
• Founded year: 1983
• Headcount: 1001-5000
• LinkedIn: pharmascience

Pharmascience is a private pharmaceutical company based in Montreal, Quebec, Canada, founded in 1983. The company specializes in the production and marketing of generic medications, including both prescription and over-the-counter drugs. With a workforce of approximately 1,845 employees, Pharmascience is dedicated to making essential treatments accessible to healthcare providers, pharmacies, and patients. The company operates with a strong commitment to employee development and community involvement, producing a wide range of medications that are distributed in over 50 countries worldwide. Pharmascience is recognized for its philanthropic efforts and has received accolades for its workplace culture, emphasizing the importance of a supportive environment for its employees. Their focus on quality and accessibility positions them as a significant player in the generic pharmaceutical industry.

Generic Drugs Distribution Insights: Key Companies

Want to Find More Generic Drugs Distribution Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!